Genetic diversity of pneumococcal surface protein A of Streptococcus pneumoniae meningitis in German children

Vaccine

Volumn 25, Issue 6, 2007, Pages 1030-1035

  Heeg, Christiane ^a   Franken, Carmen ^a   van der Linden, Mark ^a   Al Lahham, Adnan ^a   Reinert, Ralf René ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

Epidemiology; Pneumococcal; PspA; Streptococcus pneumoniae; Vaccine

Indexed keywords

MEMBRANE PROTEIN; PNEUMOCOCCUS SURFACE PROTEIN A;

ARTICLE; BACTERIAL GENE; BACTERIAL MENINGITIS; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLADISTICS; CONTROLLED STUDY; GENETIC VARIABILITY; GERMANY; HEALTH PROGRAM; HEALTH SURVEY; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; SEQUENCE ANALYSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CHILD; CHILD, PRESCHOOL; GERMANY; HUMANS; MENINGITIS, PNEUMOCOCCAL; MOLECULAR SEQUENCE DATA; PROSPECTIVE STUDIES; STREPTOCOCCUS PNEUMONIAE; VARIATION (GENETICS);

EID: 33845580503     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.09.061     Document Type: Article

References (22)

1. Musher D.M. Infections caused by Streptococcus pneumoniae: clinical spectrum, pathogenesis, immunity, and treatment. Clin Infect Dis 14 4 (1992) 801-807
2. Felmingham D., Farrell D.J., Reinert R.R., and Morrissey I. Antibacterial resistance among children with community-acquired respiratory tract infections (PROTEKT 1999-2000). J Infect 48 1 (2004) 39-55
3. Appelbaum P.C. Resistance among Streptococcus pneumoniae: implications for drug selection. Clin Infect Dis 34 12 (2002) 1613-1620
4. Fedson D.S., and Musher D.M. Pneumococcal polysaccharide vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines (2003), Saunders [chapter: 22]
5. Whitney C.G., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., Lynfield R., et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348 18 (2003) 1737-1746
6. Reinert R.R. Pneumococcal conjugate vaccines-a European perspective. Int J Med Microbiol 294 5 (2004) 277-294
7. Eskola J., Kilpi T., Palmu A., Jokinen J., Haapakoski J., Herva E., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 6 (2001) 403-409
8. Shinefield H.R., Black S., Ray P., Chang I., Lewis N., Fireman B., et al. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 18 9 (1999) 757-763
9. von Kries R., Siedler A., Schmitt H.J., and Reinert R.R. Proportion of invasive pneumococcal infections in German children preventable by pneumococcal conjugate vaccines. Clin Infect Dis 31 2 (2000) 482-487
10. von Kries R., Hermann M., Hachmeister A., Siedler A., Schmitt H.J., Al-Lahham A., et al. Prediction of the potential benefit of different pneumococcal conjugate vaccines on invasive pneumococcal disease in German children. Pediatr Infect Dis J 21 11 (2002) 1017-1023
11. Briles D.E., Hollingshead S.K., Paton J.C., Ades E.W., Novak L., van Ginkel F.W., et al. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J Infect Dis 188 3 (2003) 339-348
12. Whitney C. Effect of pneumococcal conjugate vaccine on invasive disease in the U.S. Programme and abstracts of fourth international symposium on Pneumococci and Pneumococcal diseases (ISPPD-4). Helsinki Finland, May 9-13, 2004 (2004) [abstract PSV1-02]
13. Hollingshead S.K., Becker R., and Briles D.E. Diversity of PspA: mosaic genes and evidence for past recombination in Streptococcus pneumoniae. Infect Immun 68 10 (2000) 5889-5900
14. Vela Coral M.C., Fonseca N., Castaneda E., Di Fabio J.L., Hollingshead S.K., and Briles D.E. Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children. Emerg Infect Dis 7 5 (2001) 832-836
15. Brandileone M.C., Andrade A.L., Teles E.M., Zanella R.C., Yara T.I., Di Fabio J.L., et al. Typing of pneumococcal surface protein A (PspA) in Streptococcus pneumoniae isolated during epidemiological surveillance in Brazil: towards novel pneumococcal protein vaccines. Vaccine 22 29-30 (2004) 3890-3896
16. Bogaert D., Hermans P.W., Adrian P.V., Rumke H.C., and de Groot R. Pneumococcal vaccines: an update on current strategies. Vaccine 22 17-18 (2004) 2209-2220
17. Briles D.E. Protection of the elderly from pneumococcal pneumonia with a protein-based vaccine?. Mech Ageing Dev 125 2 (2004) 129-131
18. Zysk G., Bethe G., Nau R., Koch D., Grafin Von Bassewitz V.C., Heinz H.P., et al. Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease. J Infect Dis 187 2 (2003) 330-333
19. Von Kries R., Hermann M., Al-Lahham A., Siedler A., and Reinert R.R. Will the 7-valent pneumococcal vaccine have a similar impact on all invasive pneumococcal infections in children in Germany as in the Kaiser Permanente Trial?. Eur J Pediatr 161 Suppl. (2002) S140-S143
20. Martin N.J., Kaplan E.L., Gerber M.A., Menegus M.A., Randolph M., Bell K., et al. Comparison of epidemic and endemic group G streptococci by restriction enzyme analysis. J Clin Microbiol 28 9 (1990) 1881-1886
21. Hollingshead S.K., and Briles D.E. Streptococcus pneumoniae: new tools for an old pathogen. Curr Opin Microbiol 4 1 (2001) 71-77
22. Mollerach M., Regueira M., Bonofiglio L., Callejo R., Pace J., Di Fabio J.L., et al. Invasive Streptococcus pneumoniae isolates from Argentinian children: serotypes, families of pneumococcal surface protein A (PspA) and genetic diversity. Epidemiol Infect 132 2 (2004) 177-184